Page 22 - Vaccine

Covid-19 vaccination sites drop to half in India amid shortage of doses

Number of locations down from 120,000 to 60,000 from April 3 to 7

India drug regulator asks Dr Reddy's for more data on Sputnik V vaccine

The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study

ICU beds: Maharashtra struggles, others fare better as Covid-19 cases rise

At Maharashtra, the epicentre of the second wave of Covid-19 in India, the health infrastructure is facing a fresh challenge as cases multiply

AstraZeneca has sent us legal notice for vaccine supply delay: Poonawalla

For the next one or two months, we will be prioritising supplies only to India based on the request of the government and also depending on the needs of our people, said Poonawalla

SII to start supplying 1st India-made pneumococcal conjugate jab to govt

The Serum Institute of India (SII) will start supplying the first indigenously developed pneumococcal conjugate vaccine to the Centre from Wednesday, sources said on Tuesday

Fruit vendors, security services exempted as Maharashtra revises guidelines

Petrol pumps, govt and private security services, and fruit vendors among others have been added to the list of essential services in Maharashtra

15 million doses of J&J coronavirus vaccine ruined in US by 'human error'

Errors at a manufacturing plant in the US has ruined 15 million potential doses of the Johnson & Johnson Covid-19 vaccine, The New York Times reported.

Best of BS Opinion: Backsliding without broadband, Covid-19 vaccine & more

Here's a selection of Business Standard opinion pieces for the day

Supply chain threats

Vaccine nationalism shows how the pandemic has stressed trade

A data-driven path to vaccine equity

The relative weightage of economic activities and mortality may be a serious issue, which the policymakers should decide and the model can be rebuilt based on the country's perspective

Wait for Sputnik V Covid-19 vaccine may get over in a few weeks: DRL

"We expect to get the approval in the next few weeks," said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL)

SII, Bharat Bio seek central fund injection to ramp up vaccine production

SII, Bharat Biotech want to increase production to meet domestic, foreign demand

Gujarat's Covid-19 cases cross 300,000-mark with 2,270 additions

Gujarat's COVID-19 tally crossed the 3-lakh mark and reached 3,00,866 on Sunday with the addition of 2,270 fresh cases, the state health department said.

Increase vaccine supply

Govt must fast-track approval process, fix distribution issues

India delays big exports of AstraZeneca vaccine as Covid-19 cases surge

India is, however, not officially banning Covid-19 vaccine exports. "This is a temporary move until the supply situation stabilises in the country," said a person close to the development

Adar Poonawalla rents London mansion for $69,000 a week, says report

The mansion is one of the largest residences in the neighborhood and measures about 25,000 square feet (2,322 square meters), the equivalent of about 24 average English homes

All above 45 years of age to get Covid-19 vaccine from April 1: Govt

So far, only those above 45 who had certain co-morbidities were allowed to take the vaccine after producing a letter from a registered doctor

One year on

Ravages of last year's lockdown may still affect economy

States on overdrive to reduce vaccine wastage as Covid-19 cases rise

Experts say controlling spoilage with 10-dose vials may give vax drive a shot in the arm

Vardhman Health to invest Rs 100 crore in adult immunisation outreach

Company earned Rs 500 crore as revenue in FY21 and it plans to double it to over Rs 1,000 crore.